These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 36708093)
1. Pharmaco-virological algorithm to target risk of drug resistance among a population of HIV-infected key populations in Togo. Ferré VM; Bitty-Anderson AM; Peytavin G; Lê MP; Dagnra CA; Coppée R; Gbeasor-Komlanvi FA; Descamps D; Charpentier C; Ekouevi DK J Med Virol; 2023 Feb; 95(2):e28535. PubMed ID: 36708093 [TBL] [Abstract][Full Text] [Related]
2. High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo. Dagnra AY; Vidal N; Mensah A; Patassi A; Aho K; Salou M; Monleau M; Prince-David M; Singo A; Pitche P; Delaporte E; Peeters M J Int AIDS Soc; 2011 Jun; 14():30. PubMed ID: 21663632 [TBL] [Abstract][Full Text] [Related]
3. Development and reliability of metrics to characterize types and sources of stigma among men who have sex with men and female sex workers in Togo and Burkina Faso. Grosso AL; Ketende SC; Stahlman S; Ky-Zerbo O; Ouedraogo HG; Kouanda S; Samadoulougou C; Lougue M; Tchalla J; Anato S; Dometo S; Nadedjo FD; Pitche V; Baral SD BMC Infect Dis; 2019 Mar; 19(1):208. PubMed ID: 30832604 [TBL] [Abstract][Full Text] [Related]
4. Considerable distance to reach 90-90-90 targets among female sex workers, men who have sex with men and transgender women in Port Moresby, Papua New Guinea: findings from a cross-sectional respondent-driven sampling survey. Hakim AJ; Badman SG; Weikum D; Amos A; Willie B; Narokobi R; Gabuzzi J; Pekon S; Kupul M; Hou P; Aeno H; Neo Boli R; Nembari J; Ase S; Kaldor JM; Vallely AJ; Kelly-Hanku A; Sex Transm Infect; 2020 Mar; 96(2):143-150. PubMed ID: 31182653 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and correlates of alcohol and tobacco use among key populations in Togo in 2017: a cross-sectional study. Bitty-Anderson AM; Gbeasor-Komlanvi FA; Johnson P; Sewu EK; Dagnra CA; Salou M; Blatome TJ; Jaquet A; Coffie PA; Ekouevi DK BMJ Open; 2019 Nov; 9(11):e028934. PubMed ID: 31685493 [TBL] [Abstract][Full Text] [Related]
6. Uptake of antiretroviral treatment and viral suppression among men who have sex with men and transgender women in sub-Saharan Africa in an observational cohort study: HPTN 075. Palumbo PJ; Zhang Y; Clarke W; Breaud A; Sivay M; Cummings V; Hamilton EL; Guo X; Ogendo A; Kayange N; Panchia R; Dominguez K; Chen YQ; Sandfort TGM; Eshleman SH Int J Infect Dis; 2021 Mar; 104():465-470. PubMed ID: 33440260 [TBL] [Abstract][Full Text] [Related]
7. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients. Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and factors associated with psychological distress among key populations in Togo, 2017. Tchankoni MK; Gbeasor-Komlanvi FA; Bitty-Anderson AM; Sewu EK; Zida-Compaore WIC; Alioum A; Salou M; Dagnra CA; Ekouevi DK PLoS One; 2020; 15(4):e0231726. PubMed ID: 32298337 [TBL] [Abstract][Full Text] [Related]
9. HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study. Coetzee J; Hunt G; Jaffer M; Otwombe K; Scott L; Bongwe A; Ledwaba J; Molema S; Jewkes R; Gray GE PLoS One; 2017; 12(12):e0188606. PubMed ID: 29244809 [TBL] [Abstract][Full Text] [Related]
10. Antiretroviral drug use and HIV drug resistance in female sex workers in Tanzania and the Dominican Republic. Grant-McAuley W; Fogel JM; Galai N; Clarke W; Breaud A; Marzinke MA; Mbwambo J; Likindikoki S; Aboud S; Donastorg Y; Perez M; Barrington C; Davis W; Kerrigan D; Eshleman SH PLoS One; 2020; 15(10):e0240890. PubMed ID: 33119663 [TBL] [Abstract][Full Text] [Related]
11. Antiretroviral treatment coverage for men who have sex with men and female sex workers living with HIV in Cameroon. Holland CE; Papworth E; Billong SC; Tamoufe U; LeBreton M; Kamla A; Eloundou J; Managa F; Yomb Y; Fokam P; Gbais H; Mfochive I; Ketende S; Baral S J Acquir Immune Defic Syndr; 2015 Mar; 68 Suppl 2():S232-40. PubMed ID: 25723989 [TBL] [Abstract][Full Text] [Related]
12. The feasibility of modified HIV and antiretroviral drug testing using self-collected dried blood spots from men who have sex with men. Luo W; Sullivan V; Chavez PR; Wiatrek SE; Zlotorzynska M; Martin A; Rossetti R; Sanchez T; Sullivan P; MacGowan RJ; Owen SM; Masciotra S BMC Infect Dis; 2021 May; 21(1):423. PubMed ID: 33952212 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey. Ferré VM; Ekouevi DK; Gbeasor-Komlanvi FA; Collin G; Le Hingrat Q; Tchounga B; Salou M; Descamps D; Charpentier C; Dagnra AC Clin Microbiol Infect; 2019 Dec; 25(12):1560.e1-1560.e7. PubMed ID: 31051265 [TBL] [Abstract][Full Text] [Related]
15. High level of treatment failure and drug resistance to first-line antiretroviral therapies among HIV-infected children receiving decentralized care in Senegal. Cissé AM; Laborde-Balen G; Kébé-Fall K; Dramé A; Diop H; Diop K; FatouNiasse-Traoré ; Coulibaly M; Have NN; Vidal N; Thiam S; Wade AS; Peeters M; Taverne B; Msellati P; Touré-Kane C BMC Pediatr; 2019 Feb; 19(1):47. PubMed ID: 30722780 [TBL] [Abstract][Full Text] [Related]
16. Use of rilpivirine in HIV-1-infected individuals in routine clinical practice from 2012 to 2017 in France. Potard V; Gallien S; Canestri A; Costagliola D; J Antimicrob Chemother; 2021 Jan; 76(2):467-476. PubMed ID: 33257955 [TBL] [Abstract][Full Text] [Related]
17. Sexual practices, sexual behavior and HIV risk profile of key populations in Nigeria. Ochonye B; Folayan MO; Fatusi AO; Bello BM; Ajidagba B; Emmanuel G; Umoh P; Yusuf A; Jaiyebo T BMC Public Health; 2019 Sep; 19(1):1210. PubMed ID: 31477063 [TBL] [Abstract][Full Text] [Related]
18. HIV-1 infection in South Kivu (Democratic Republic of Congo): high genotypic resistance to antiretrovirals. Duhant A; Kusinza B; Tantet C; Bisimwa B; Gare M; Masemo B; Alloui C; Ntakwinjan M; Mechai F; Le MP; Gerber A; Muhigirwa B; Peytavin G; Gordien E; Brichler S; Mukwege M; Le Gal F J Antimicrob Chemother; 2023 Jul; 78(7):1732-1739. PubMed ID: 37254601 [TBL] [Abstract][Full Text] [Related]
19. Alarming rates of virological failure and drug resistance in patients on long-term antiretroviral treatment in routine HIV clinics in Togo. Konou AA; Dagnra AY; Vidal N; Salou M; Adam Z; Singo-Tokofai A; Delaporte E; Prince-David M; Peeters M AIDS; 2015 Nov; 29(18):2527-30. PubMed ID: 26558549 [TBL] [Abstract][Full Text] [Related]
20. Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients. Meybeck A; Alidjinou EK; Huleux T; Boucher A; Tetart M; Choisy P; Bocket L; Ajana F; Robineau O AIDS Patient Care STDS; 2020 Feb; 34(2):51-58. PubMed ID: 32049556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]